What is the correct dosage of entrectinib? How to take medicine correctly?
Entrectinib is a targeted therapy drug mainly used to treat certain types of cancer, especially NTRK gene fusion-positive, ALK or ROS1 gene mutation-positive non-small cell lung cancer and other tumors. When using this drug, patients should use it correctly according to the doctor's prescription and drug instructions to ensure the best efficacy of the drug.
Dose Adjustment: For patients who experience serious adverse reactions, the dose may need to be adjusted based on physician recommendations. Common adverse reactions include gastrointestinal discomfort, liver function damage, etc. In these cases, your doctor may recommend reducing the dose or suspending treatment until side effects are relieved.
In summary, the correct use of entrectinib is critical to therapeutic efficacy. Patients should communicate with their doctors regularly while taking the medication and report any discomfort in a timely manner so that the treatment plan can be adjusted.
Reference: https://www.roche.com/products/rozlytrek
Dosage: The standard recommended dose for adult and pediatric patients (12 years and older) is 600 mg orally once daily. This medication should be taken at the same time each day, and preferably with food to avoid fasting. Patients should swallow the medication whole and do not chew or crush the medication. Specific dosage and treatment regimens may be individualized based on the patient's physical condition, condition, and response to medications.
Dose Adjustment: For patients who experience serious adverse reactions, the dose may need to be adjusted based on physician recommendations. Common adverse reactions include gastrointestinal discomfort, liver function damage, etc. In these cases, your doctor may recommend reducing the dose or suspending treatment until side effects are relieved.
In summary, the correct use of entrectinib is critical to therapeutic efficacy. Patients should communicate with their doctors regularly while taking the medication and report any discomfort in a timely manner so that the treatment plan can be adjusted.
Reference: https://www.roche.com/products/rozlytrek
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)